This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (17)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

VICTOR T. CURTIN, MD; EDWARD W. D. NORTON, MD

Arch Ophthalmol. 1963;70(2):150-157.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Since the development of the Zeiss light coagulator, the treatment of uveal malignant melanomas has been under evaluation. Meyer-Schwickerath has discussed and reported its use in many papers,^1-4 and other authors have reported their cases.^5-7 The efficacy the the treatment must ultimately depend upon the ability of light energy to destroy tumor cells in a predictable manner without secondary damage to the eye. The purpose of this paper is to illustrate the pathological changes in choroidal melanomas after photocoagulation and to evaluate its present status in treatment of malignant melanomas of the choroid.

Method

Light energy of high intensity was applied with the Zeiss photocoagulator to portions of choroidal malignant melanomas in four human eyes prior to enucleation. The load setting ranged from green III to overload red III, and the duration of exposure ranged from one to three seconds. The eyes were removed 2, 6, 8, and . . . [Full Text PDF of this Article]

Author Affiliations
Miami, Fla

Department of Ophthalmology, University of Miami School of Medicine.

Footnotes
Submitted for publication Oct 22, 1962.

This work was supported in part by the Florida Lions Eye Bank, District 35 A.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?